Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Charmacy Pharmaceutical Co., Ltd. has announced a delay in the publication of its circular related to the New Framework Agreements, now expected to be released by December 13, 2024. The extension is required to finalize certain information, ensuring comprehensive details for investors. This delay might affect stakeholders anticipating updates in the company’s strategic agreements.
For further insights into HK:2289 stock, check out TipRanks’ Stock Analysis page.